1674-0440
2010 Issue 1
..............page:1-7
Introduction to the U.S. FDA\'s new drug approvals in 2009
tang zhong ming
tang zhong ming
..............page:8-15,46
..............page:64-66
Effects of iptakalim on renal injury induced by lipopolysaccharide, oleic acid and diethylene glycol
zhao ying ; zhang yan fang ; long chao liang ; cui wen yu ; pan zhi yuan ; wang hai
zhao ying ; zhang yan fang ; long chao liang ; cui wen yu ; pan zhi yuan ; wang hai
..............page:51-55
..............page:56-59
Calcium sensitizer levosimendan and piperphentonamine: research advances
yang xiang yang ; li ruo bing ; wan hua yin
yang xiang yang ; li ruo bing ; wan hua yin
..............page:32-35
Bioequivalence of bicalutamide tablet in healthy volunteers
sun ying ying ; wei yang ; wang zuo shen ; shao qing xiang
sun ying ying ; wei yang ; wang zuo shen ; shao qing xiang
..............page:43-46
In vitro assessments of nanomaterial toxicity
clinton f;grainger jdw; li zuo ; jin yi guang
clinton f;grainger jdw; li zuo ; jin yi guang
..............page:67-69,72
Blood-brain barrier transport of drug-loaded nanoparticle: research advances
wang bin yan ; xia ai xiao ; chen ping ping ; ni ling ; liu fu he ; li fan zhu
wang bin yan ; xia ai xiao ; chen ping ping ; ni ling ; liu fu he ; li fan zhu
..............page:40-42
Hepatic cellular microenvironment: a novel drug target for anti-hepatic fibrosis
liu qing shan ; zhang zuo zuo ; cui jian ; tian yan ze ; pang zong ran
liu qing shan ; zhang zuo zuo ; cui jian ; tian yan ze ; pang zong ran
..............page:21-23,59
Progress on brain-targeting non-viral gene delivery systems
huang rong qin ; ke wei lun ; jiang chen ; pei yuan ying
huang rong qin ; ke wei lun ; jiang chen ; pei yuan ying
..............page:36-39
CC chemokine receptor 4 and its inhibitors: research advances
sun chao zuo ; wei ju
sun chao zuo ; wei ju
..............page:29-31
..............page:73-77
Pathogenesy and pharmacotherapy of hyperuricemia: research advances
liu jia ; li ling
liu jia ; li ling
..............page:24-28
..............page:78-80
Anti-aging effect of polypeptides from Fructus Lycii on D-gal induced aging model mice and the possible mechanism
jiang wan zhi ; zhang hong quan
jiang wan zhi ; zhang hong quan
..............page:47-50
..............page:60-63
Precaution, cyclooxygenase inhibition,and cardiovascular risk
ritter jm;harding i;warren jb; du yuan ; ren ru tong
ritter jm;harding i;warren jb; du yuan ; ren ru tong
..............page:70-72
Studies on antiestrogen compounds and their structure-activity relationships
lv bo ; wang lin ; xue pei feng
lv bo ; wang lin ; xue pei feng
..............page:16-20